Prognostic impact of aberrant t/NK cell marker expression in AML.

被引：0
|
作者：
Saste, Abhijit Balkrishna
Gulati, Rohit
Kuriakose, Philip
Inamdar, Kedar
Karner, Kristin
Carey, John
Menon, Madhu
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Henry Ford Hosp, Northville, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18502
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Differences in reconstitution of NK-cell subsets and expression of effector molecules after HLA-identical and haploidentical allogeneic stem cell transplantation in patients with AML.
    Platzbecker, U
    Schulze, A
    Oelschlagel, U
    Schirutschke, H
    Schmitz, M
    Ehninger, G
    Bornhauser, M
    BLOOD, 2005, 106 (11) : 407A - 408A
  • [22] THE PROGNOSTIC IMPACT OF ABERRANT ANTIGEN EXPRESSION IN ACUTE LEUKEMIAS
    Yucel, O.
    Salim, O.
    Ulubahsi, M.
    Timuragaoglu, A.
    HAEMATOLOGICA, 2013, 98 : 525 - 525
  • [23] Aberrant MUC13 expression as prognostic marker for gastric cancer
    Oosterlinck, B.
    Breugelmans, T.
    De Man, J.
    Geboes, K.
    Kupcinskas, J.
    Link, A.
    De Winter, B.
    Smet, A.
    HELICOBACTER, 2020, 25 : 54 - 54
  • [24] Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia
    Dorwal, Pranav
    Mehra, Simmi
    Pande, Amit
    Jain, Dharmendra
    Smeeta, G.
    Sachdev, Ritesh
    Raina, Vimarsh
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2015, 88 (05) : 348 - 351
  • [25] Expression and prognostic impact of XIAP expression in acute myelogenous leukemia (AML).
    Kornblau, SM
    Andreeff, MA
    Qui, YH
    Patel, S
    Thomas, D
    Giles, F
    Beran, M
    Estrov, Z
    BLOOD, 1999, 94 (10) : 207B - 207B
  • [26] Expression pattern of bcl-2 and bcl-x on t(8;21) AML.
    Shikami, M
    Nishii, K
    Miwa, H
    Shiku, H
    Kita, K
    BLOOD, 1997, 90 (10) : 3613 - 3613
  • [27] Gene expression profiles of t(11q23)/MLL positive ALL and AML.
    Kohlmann, A
    Schoch, C
    Dugas, M
    Schnittger, S
    Hiddemann, W
    Haferlach, T
    Kern, W
    BLOOD, 2002, 100 (11) : 84A - 84A
  • [28] Nuclear Expression of MATK Is a Novel Marker of Type II Enteropathic T-Cell Lymphoma and NK/T Cell Lymphoma
    Tan, S. Y.
    Ooi, A. S.
    Ngeow, J.
    Tan, L.
    Teh, B. T.
    LABORATORY INVESTIGATION, 2010, 90 : 324A - 324A
  • [29] Nuclear Expression of MATK Is a Novel Marker of Type II Enteropathic T-Cell Lymphoma and NK/T Cell Lymphoma
    Tan, S. Y.
    Ooi, A. S.
    Ngeow, J.
    Tan, L.
    Teh, B. T.
    MODERN PATHOLOGY, 2010, 23 : 324A - 324A
  • [30] Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies
    Krauter, Juergen
    Heil, Gerhard
    Hoelzer, Dieter
    Martin, Hans
    Ottmann, Oliver G.
    Finke, Juergen
    Luebbert, Michael
    Heit, Wolfgang
    Fiedler, Walter
    Kanz, Lothar
    Schlimok, Guenter
    Kirchner, Hartmut
    Raghavachar, Aruna
    Brugger, Wolfram
    Doehner, Hartmut
    Ganser, Arnold
    BLOOD, 2008, 112 (11) : 134 - 134
12345